Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Seeber

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Translational Lung Cancer Research|January 24, 2022
The DNA damage repair-related gene <i>PKMYT1</i> is a potential biomarker in various malignanciesChangjian Shao, Yuanyong Wang, Minghong Pan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.
Genes & Cancer|January 5, 2017
Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE projectAndreas Seeber, Guenther Gastl, Christian Ensinger, et al.
Lung Cancer (Amsterdam, Netherlands)|July 27, 2021
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibitionFlorian Kocher, Piotr Tymoszuk, Arno Amann, et al.
Therapeutic Advances in Urology|March 17, 2025
Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case reportNils C H van Creij, Gerald Klinglmair, Leonhard Gruber, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2016
Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based studyAnnalisa Trama, Laura Botta, Nicola Nicolai, et al.
Molecular Cancer Research : MCR|April 17, 2023
BZW2 Inhibition Reduces Colorectal Cancer Growth and MetastasisSumit Agarwal, Farrukh Afaq, Prachi Bajpai, et al.
Journal of Orthopaedic Surgery and Research|May 1, 2026
Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma RegistryMaria Anna Smolle, Sonja Hasenschwandtner, Andreas Reichinger, et al.
Translational Lung Cancer Research|July 23, 2021
Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklistYongjie Yang, Jingli Lu, Yanfang Ma, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2015
Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registryFlorian Kocher, Wolfgang Hilbe, Andreas Seeber, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Translational Lung Cancer Research|January 24, 2022
The DNA damage repair-related gene <i>PKMYT1</i> is a potential biomarker in various malignanciesChangjian Shao, Yuanyong Wang, Minghong Pan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.
Genes & Cancer|January 5, 2017
Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE projectAndreas Seeber, Guenther Gastl, Christian Ensinger, et al.
Lung Cancer (Amsterdam, Netherlands)|July 27, 2021
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibitionFlorian Kocher, Piotr Tymoszuk, Arno Amann, et al.
Therapeutic Advances in Urology|March 17, 2025
Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case reportNils C H van Creij, Gerald Klinglmair, Leonhard Gruber, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2016
Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based studyAnnalisa Trama, Laura Botta, Nicola Nicolai, et al.
Molecular Cancer Research : MCR|April 17, 2023
BZW2 Inhibition Reduces Colorectal Cancer Growth and MetastasisSumit Agarwal, Farrukh Afaq, Prachi Bajpai, et al.
Journal of Orthopaedic Surgery and Research|May 1, 2026
Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma RegistryMaria Anna Smolle, Sonja Hasenschwandtner, Andreas Reichinger, et al.
Translational Lung Cancer Research|July 23, 2021
Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklistYongjie Yang, Jingli Lu, Yanfang Ma, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2015
Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registryFlorian Kocher, Wolfgang Hilbe, Andreas Seeber, et al.
Pageof 12